Notifications Bell

Markets are bracing themselves for another round of quarterly earnings - Monday Review, February 1

Markets are bracing themselves for another round of quarterly earnings - Monday Review, February 1

Global shares rally amid COVID-19 vaccine rollout, and expected tech earnings

The US

Stocks closed in the green as another busy week of quarterly results is in sight, with Amazon and Alphabet due to report in the following days. USA30 rose 0.76%, while USA500 was up 1.57%. TECH100 jumped 2.55%.

Crude oil traded 0.8% higher at $52.61 per barrel.

Gold closed at $1,864.60 per ounce after it went up 0.8%.

The Dollar Index was seen at 90.876.

Asia and Australia

As the Reserve Banks decided to inject more money into their countries battered economies, markets were up on Monday. Japan225 added 1.2%.

HongKong45 gained 0.70%.

Down under, Australia200 closed 0.62% higher after the RBA handed down its latest policy, and Perth was put into a five-day lockdown after a COVID-19 case was reported in the city.

USD/JPY traded at 104.772 after it went up 0.03%.


The benchmarks ended higher driven by the fact that the UK managed to vaccinate almost 9 million people. Also, the Eurozone manufacturing PMI edged to 54.8, topping expectations. Germany30 traded 1.2% higher, while France40 rose 1%. UK100 climbed 0.8%.

Brent oil rose 1% to $55.57 a barrel.

EUR/USD lost 0.3% trading at 1.2095.


This information prepared by is not an offer or a solicitation for the purpose of purchase or sale of any financial products referred to herein or to enter into any legal relations, nor an advice or a recommendation with respect to such financial products.

This information is prepared for general circulation. It does not have regard to the specific investment objectives, financial situation or the particular needs of any recipient.

You should independently evaluate each financial product and consider the suitability of such a financial product, by taking into account your specific investment objectives, financial situation or particular needs, and by consulting an independent financial adviser as needed, before dealing in any financial products mentioned in this document.

This information may not be published, circulated, reproduced or distributed in whole or in part to any other person without the Company’s prior written consent.

Past performance is not always indicative of likely or future performance. Any views or opinions presented are solely those of the author and do not necessarily represent those of